vimarsana.com

மருந்து இல் ஹார்வர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2021 APS Board of Directors Election

2021 APS Board of Directors Election
psychologicalscience.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychologicalscience.org Daily Mail and Mail on Sunday newspapers.

New Clinical Trial in MDR-TB Care to Support Hardest to Treat Patients Globally

Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Posted on Dec 22, 2020 An extensively drug-resistant tuberculosis patient is examined as part of the endTB project at Sergio E. Bernales Hospital in Carabayllo, a northern district of Lima, Peru. Photo by William Castro Rodriguez for Partners In Health Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multidrug (MDR)- and extensively drug resistant strains are particularly worrisome to patients and clinicians, and they are rapidly spreading across countries with the least resources to tackle them.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.